Results 311 to 320 of about 23,125,138 (369)

Interleukin-2–based therapies in cancer

Science Translational Medicine, 2022
Molecular insights into the mechanism of beneficial and adverse effects of interleukin-2 (IL-2) have resulted in the development of improved IL-2 formulations with IL-2 receptor bias and tissue-targeting properties.
M. E. Raeber, Dilara Şahin, O. Boyman
semanticscholar   +1 more source

Interleukin 2

Reactions weekly, 2017
David Klatzmann, Thomas R. Malek
openaire   +2 more sources

The Interleukin -2

Acta Clinica Belgica, 1987
SummaryDiscovered in 1976, the lymphokine interleukin-2, intensively studied during the last years, plays a major role in the regulation of the immune function. The authors reviewing its principal properties, anticipate forthcoming prospects of considerable implications in therapy.Acta Clin. Bclg. 42, 4: 255–68.
M, Hiden, P, Nève
openaire   +2 more sources

Interleukin 2 receptors

Leukemia Research, 1990
Interleukin 2 receptors (IL-2-R) are composed of (at least) two chains: the alpha chain (or p55 or Tac) and the beta chain (or p70 or p75). The association of both chains constitutes high affinity IL2-R complexes (Kd congruent to 10-100 pM), whereas the alpha-chain or the beta chain alone bind IL-2 with low (Kd congruent to 5-50 nM) and intermediate ...
M, Allouche   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy